D M Mannino1, K J Davis. 1. Division of Pulmonary and Critical Care Medicine, University of Kentucky Medical Center, 740 S Limestone, K-528, Lexington, KY 40536, USA. dmannino@uky.edu
Abstract
OBJECTIVE: To determine the risk factors for and outcomes associated with the rapid decline in lung function in a cohort of elderly US adults. METHODS: Data from 4923 adult participants aged 65 years and older at baseline in the Cardiovascular Health Study were analysed. Subjects were classified using a modification of the GOLD criteria for chronic obstructive pulmonary disease (COPD) and a "restricted" category (FEV1/FVC>or=70% and FVC<80% predicted) was added. Cox proportional hazard models were used to determine the risk of lung function decline over 4 years on subsequent mortality and COPD hospital admissions after adjusting for age, race, sex, smoking status, and other factors. RESULTS: Of the participants in the initial cohort, 3388 (68.8%) had spirometric tests at the year 4 visit. Participants with GOLD stages 3 or 4 COPD at baseline were less likely than normal subjects to have follow up spirometric tests (52.7% v 77.9%, p<0.01) and were more likely to be in the most rapidly declining quartile of FEV1 (28.2% v 21.3%, p<0.01) with an annual loss of FEV1 of at least 3.5%. Overall, being in the most rapidly declining quartile of FEV1 from baseline to year 4 was associated with an increased risk of admission to hospital for COPD (adjusted hazard ratio (HR) 1.6, 95% confidence interval (CI) 1.3 to 2.0) and all-cause death (adjusted HR 1.5, 95% CI 1.2 to 1.7) over an additional 7 years of follow up. CONCLUSION: More rapid decline in lung function is independently associated with a modest increased risk of hospital admissions and deaths from COPD in an elderly cohort of US participants.
OBJECTIVE: To determine the risk factors for and outcomes associated with the rapid decline in lung function in a cohort of elderly US adults. METHODS: Data from 4923 adult participants aged 65 years and older at baseline in the Cardiovascular Health Study were analysed. Subjects were classified using a modification of the GOLD criteria for chronic obstructive pulmonary disease (COPD) and a "restricted" category (FEV1/FVC>or=70% and FVC<80% predicted) was added. Cox proportional hazard models were used to determine the risk of lung function decline over 4 years on subsequent mortality and COPD hospital admissions after adjusting for age, race, sex, smoking status, and other factors. RESULTS: Of the participants in the initial cohort, 3388 (68.8%) had spirometric tests at the year 4 visit. Participants with GOLD stages 3 or 4 COPD at baseline were less likely than normal subjects to have follow up spirometric tests (52.7% v 77.9%, p<0.01) and were more likely to be in the most rapidly declining quartile of FEV1 (28.2% v 21.3%, p<0.01) with an annual loss of FEV1 of at least 3.5%. Overall, being in the most rapidly declining quartile of FEV1 from baseline to year 4 was associated with an increased risk of admission to hospital for COPD (adjusted hazard ratio (HR) 1.6, 95% confidence interval (CI) 1.3 to 2.0) and all-cause death (adjusted HR 1.5, 95% CI 1.2 to 1.7) over an additional 7 years of follow up. CONCLUSION: More rapid decline in lung function is independently associated with a modest increased risk of hospital admissions and deaths from COPD in an elderly cohort of US participants.
Authors: W van Pelt; G J Borsboom; B Rijcken; J P Schouten; B C van Zomeren; P H Quanjer Journal: Am J Respir Crit Care Med Date: 1994-05 Impact factor: 21.405
Authors: C M Burchfiel; E B Marcus; D S Sharp; P L Enright; B L Rodriguez; K H Masaki; L J Hwang; J D Curb Journal: Ann Epidemiol Date: 1996-05 Impact factor: 3.797
Authors: Stacey E Alexeeff; Augusto A Litonjua; David Sparrow; Pantel S Vokonas; Joel Schwartz Journal: Am J Respir Crit Care Med Date: 2007-08-02 Impact factor: 21.405
Authors: Javier J Zulueta; Juan P Wisnivesky; Claudia I Henschke; Rowena Yip; Ali O Farooqi; Dorothy I McCauley; Mildred Chen; Daniel M Libby; James P Smith; Mark W Pasmantier; David F Yankelevitz Journal: Chest Date: 2011-10-20 Impact factor: 9.410
Authors: Hwa Mu Lee; Yanglu Zhao; Michael A Liu; David Yanez; Mercedes Carnethon; R Graham Barr; Nathan D Wong Journal: Clin Cardiol Date: 2018-07-17 Impact factor: 2.882
Authors: Maria C Mirabelli; John S Preisser; Laura R Loehr; Sunil K Agarwal; R Graham Barr; David J Couper; John L Hankinson; Noorie Hyun; Aaron R Folsom; Stephanie J London Journal: Respir Med Date: 2016-02-11 Impact factor: 3.415
Authors: Mary E Tinetti; Gail McAvay; Sandy S Chang; Yuming Ning; Anne B Newman; Annette Fitzpatrick; Terri R Fried; Tamara B Harris; Michael C Nevitt; Suzanne Satterfield; Kristine Yaffe; Peter Peduzzi Journal: J Am Geriatr Soc Date: 2011-08-24 Impact factor: 5.562
Authors: Jacob Louis Marott; Truls Sylvan Ingebrigtsen; Yunus Çolak; Jørgen Vestbo; Peter Lange Journal: Am J Respir Crit Care Med Date: 2020-07-15 Impact factor: 21.405
Authors: Y Kubota; S J London; M Cushman; A M Chamberlain; W D Rosamond; S R Heckbert; N Zakai; A R Folsom Journal: J Thromb Haemost Date: 2016-11-08 Impact factor: 5.824